Johanna Thornblad - 30 Mar 2026 Form 3 Insider Report for HIVE Digital Technologies Ltd. (HIVE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
31 Mar 2026, 15:29:02 UTC
Next SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Johanna Thornblad

Key filing fact

Johanna Thornblad filed Form 3 for HIVE Digital Technologies Ltd. (HIVE) on 31 Mar 2026.

Key facts

  • This page summarizes Johanna Thornblad's Form 3 filing for HIVE Digital Technologies Ltd. (HIVE).
  • 0 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 31 Mar 2026, 15:29.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002122913 Primary reporting owner

Thornblad Johanna

Relationship
Country Site President-Sweden
Address
7900 CALLAGHAN ROAD, SUITE 128, SAN ANTONIO
Signature
/s/ Johanna Thornblad
Signature date
30 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIVE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
138,571
Date
30 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$18.13
Footnotes
F1, F2
HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$15.13
Footnotes
F3, F4
HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,400
Exercise price
$4.08
Footnotes
F5, F6
HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,000
Exercise price
$4.94
Footnotes
F7, F8
HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
120,000
Exercise price
$0.000000
Footnotes
F9
HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
60,000
Exercise price
$0.000000
Footnotes
F10
HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200,000
Exercise price
$0.000000
Footnotes
F11
HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200,000
Exercise price
$0.000000
Footnotes
F12
HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200,000
Exercise price
$0.000000
Footnotes
F13
HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200,000
Exercise price
$0.000000
Footnotes
F14
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 14 footnotes

Footnote F1

These options were granted on April 6, 2021 and are fully vested as of the date hereof.

Footnote F2

Represents an exercise price of $25.15 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.

Footnote F3

These options were granted on December 8, 2021 and are fully vested as of the date hereof.

Footnote F4

Represents an exercise price of $21.00 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.

Footnote F5

These options were granted on August 26, 2022 and are fully vested as of the date hereof.

Footnote F6

Represents an exercise price of $5.66 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.

Footnote F7

These options were granted on July 6, 2023 and are fully vested as of the date hereof.

Footnote F8

Represents an exercise price of $6.86 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.

Footnote F9

Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock. The RSUs were issued on November 5, 2024, and 75,000 have vested, with the remaining 45,000 vesting in 3 equal installments on May 5, 2026, August 5, 2026, and November 5, 2026.

Footnote F10

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on February 14, 2025 and are fully vested as of the date hereof.

Footnote F11

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on April 17, 2025 and will vest in one installment on April 17, 2026.

Footnote F12

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 8, 2025 and will vest in one installment on July 8, 2026.

Footnote F13

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on October 31, 2025 and will vest in one installment on October 31, 2026.

Footnote F14

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on March 16, 2026 and will vest in one installment on March 16, 2027.

SEC remarks

The Board of Directors of HIVE Digital Technologies Ltd. (the "Company" ) has determined that the Company no longer qualifies as a foreign private issuer. As a result, effective April 1, 2026, the Company is required to comply with the reporting requirements and use the filing forms applicable to U.S. public companies under U.S. securities laws, including reports required under Section 16 of the U.S. Securities Exchange Act of 1934, as amended. The Reporting Person is filing this Form 3 in connection with this transition. Exhibit 24 Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .